Vaccinex Stock Profit Margin
Vaccinex fundamentals help investors to digest information that contributes to Vaccinex's financial success or failures. It also enables traders to predict the movement of Vaccinex Stock. The fundamental analysis module provides a way to measure Vaccinex's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaccinex stock.
Vaccinex |
Vaccinex Company Profit Margin Analysis
Vaccinex's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Vaccinex has a Profit Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The profit margin for all United States stocks is 100.0% lower than that of the firm.
Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
All Next | Launch Module |
Vaccinex Fundamentals
Return On Equity | -7.59 | ||||
Return On Asset | -4.96 | ||||
Current Valuation | 1.59 M | ||||
Shares Outstanding | 2.68 M | ||||
Shares Owned By Insiders | 11.50 % | ||||
Shares Owned By Institutions | 51.30 % | ||||
Number Of Shares Shorted | 62.11 K | ||||
Price To Book | 7.34 X | ||||
Price To Sales | 4.34 X | ||||
Revenue | 570 K | ||||
Gross Profit | (13.7 M) | ||||
EBITDA | (19.75 M) | ||||
Net Income | (20.25 M) | ||||
Cash And Equivalents | 11.4 M | ||||
Cash Per Share | 0.27 X | ||||
Total Debt | 247 K | ||||
Debt To Equity | 0.02 % | ||||
Current Ratio | 8.22 X | ||||
Book Value Per Share | (2.59) X | ||||
Cash Flow From Operations | (17.23 M) | ||||
Short Ratio | 0.60 X | ||||
Earnings Per Share | 7.42 X | ||||
Target Price | 7.0 | ||||
Number Of Employees | 37 | ||||
Beta | 0.99 | ||||
Market Capitalization | 2.86 M | ||||
Total Asset | 3.63 M | ||||
Retained Earnings | (339.93 M) | ||||
Working Capital | (2.57 M) | ||||
Net Asset | 3.63 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Vaccinex Stock
If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |